Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine), Hib
Vaxem Hib · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Arm 1 | ACTIVE_COMPARATOR | - |
| Arm 2 | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine) | BIOLOGICAL | Comparator study of two commercially available Haemophilus influenzae type b (Hib) vaccines. |
| Hiberix (Haemophilus influenzae type b (Hib) vaccine) | BIOLOGICAL | Comparator study of two commercially available Haemophilus influenzae type b (Hib) vaccines. |
Inclusion Criteria: * Toddlers 12-18 months of age who have previously participated in study M37P2. Exclusion Criteria: * Prior Hib booster administration. * History of serious reaction(s) following vaccination. * Vaccination within 14 days of study vaccination. * Known or suspected immune impair...
Vaxem Hib is a vaccine used to prevent Haemophilus influenzae type b (Hib) infection. Hib is a bacterial infection that can cause serious illness, particularly in young children. The vaccine is intended for immunization against Hib disease, including use as a booster dose in toddlers.
Vaxem Hib is developed by Novartis AG, which trades under the ticker NVS. Novartis is the company responsible for the vaccine's development and clinical evaluation.
Vaxem Hib has been evaluated in Phase 3 clinical development. One Phase 3 trial has been completed, and no trials are currently active. The vaccine is investigational and is not described as approved.
Vaxem Hib has been studied in a completed Phase 3 trial, NCT01025544, titled a study in toddlers aged 12 to 18 months comparing a booster dose of Vaxem Hib and Hiberix vaccines for the prevention of Haemophilus influenzae type b infections in China. The trial enrolled 846 healthy volunteers.
No, Vaxem Hib and Hiberix are different vaccines. They were compared head to head as booster doses in a Phase 3 trial in China. Vaxem Hib is also known as Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine).